MTB
73
4
CNX
49
3
EW
58
5
FE
48
-4
RCL
68
4
KSS
62
3
BAX
38
-12
SHW
43
-10
CA
30
3
VRTX
53
5
PCG
74
2
V
52
2
FDX
74
3
PFE
33
-8
KMB
31
-11
NFLX
40
3
XYL
33
6
UNP
38
2
OXY
40
2
EXPD
51
16
MTB
73
4
CNX
49
3
EW
58
5
FE
48
-4
RCL
68
4
KSS
62
3
BAX
38
-12
SHW
43
-10
CA
30
3
VRTX
53
5
PCG
74
2
V
52
2
FDX
74
3
PFE
33
-8
KMB
31
-11
NFLX
40
3
XYL
33
6
UNP
38
2
OXY
40
2
EXPD
51
16
Financhill
Back

Invesco S&P 500 Eql Wght ETF Vs. Nektar Therapeutics Sector Stock Comparison

Buy
59

RSP
Invesco S&P 500 Eql Wght ETF

Last Price:
$192.85
Seasonality Move:
1.76%
Sell
46

NKTR
Nektar Therapeutics

Last Price:
$46.82
Seasonality Move:
6.44%
Buy
59
Invesco S&P 500 Eql Wght ETF (RSP) is a Buy

Is Invesco S&P 500 Eql Wght ETF a Buy, Sell or Hold?

  • The current Invesco S&P 500 Eql Wght ETF [RSP] share price is $192.88. The Score for RSP is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • RSP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $46.84. The Score for NKTR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RSP Stock Price Chart

What is Invesco S&P 500 Eql Wght ETF's stock price today?

  • The Invesco S&P 500 Eql Wght ETF share price today is $192.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RSP is experiencing slight buying pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $46.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.

RSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 36.17 Buy
Relative Strength Index (14 RSI): 57.53 Buy
Chaikin Money Flow: 1607153 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (186.62 - 193.22) Buy
Bollinger Bands (100): (185.6 - 191.08) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.95 Sell
Relative Strength Index (14 RSI): 38.83 Sell
Chaikin Money Flow: 857593 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.69 - 61.39) Sell
Bollinger Bands (100): (34.99 - 62.73) Sell

RSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 193.01 Sell
20-day SMA: 191.21 Buy
50-day SMA: 189.25 Buy
200-day SMA: 181.83 Buy
8-day EMA: 101.86 Buy
20-day EMA: 49.88 Buy
50-day EMA: 21.75 Buy
200-day EMA: 5.68 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.29 Sell
20-day SMA: 55.51 Sell
50-day SMA: 57.37 Sell
200-day SMA: 31.53 Buy
8-day EMA: 49.58 Sell
20-day EMA: 53.48 Sell
50-day EMA: 54.29 Sell
200-day EMA: 38.34 Buy

Invesco S&P 500 Eql Wght ETF Earnings Growth & RSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and a decrease next year of $3.54 per share.

Invesco S&P 500 Eql Wght ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):